Logo image of OMI

OWENS & MINOR INC (OMI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:OMI - US6907321029 - Common Stock

3.01 USD
+0.06 (+2.03%)
Last: 12/12/2025, 8:04:00 PM
3.07 USD
+0.06 (+1.99%)
After Hours: 12/12/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, OMI scores 3 out of 10 in our fundamental rating. OMI was compared to 100 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. OMI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year OMI was profitable.
In the past year OMI has reported a negative cash flow from operations.
In multiple years OMI reported negative net income over the last 5 years.
In the past 5 years OMI always reported a positive cash flow from operatings.
OMI Yearly Net Income VS EBIT VS OCF VS FCFOMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

With a Return On Assets value of -33.21%, OMI is not doing good in the industry: 86.00% of the companies in the same industry are doing better.
The Return On Invested Capital of OMI (10.36%) is better than 82.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OMI is below the industry average of 9.44%.
The 3 year average ROIC (6.37%) for OMI is below the current ROIC(10.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROIC 10.36%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
OMI Yearly ROA, ROE, ROICOMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

With a Operating Margin value of 3.07%, OMI perfoms like the industry average, outperforming 57.00% of the companies in the same industry.
In the last couple of years the Operating Margin of OMI has grown nicely.
Looking at the Gross Margin, with a value of 26.13%, OMI is in line with its industry, outperforming 52.00% of the companies in the same industry.
OMI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 26.13%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
OMI Yearly Profit, Operating, Gross MarginsOMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1

2. Health

2.1 Basic Checks

OMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for OMI has been increased compared to 1 year ago.
Compared to 5 years ago, OMI has more shares outstanding
The debt/assets ratio for OMI has been reduced compared to a year ago.
OMI Yearly Shares OutstandingOMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OMI Yearly Total Debt VS Total AssetsOMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.41, we must say that OMI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OMI (1.41) is worse than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACC1.54
WACC6.72%
OMI Yearly LT Debt VS Equity VS FCFOMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.86 indicates that OMI may have some problems paying its short term obligations.
OMI has a worse Current ratio (0.86) than 78.00% of its industry peers.
OMI has a Quick Ratio of 0.86. This is a bad value and indicates that OMI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OMI (0.84) is worse than 74.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.84
OMI Yearly Current Assets VS Current LiabilitesOMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

OMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.29%.
Measured over the past years, OMI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.10% on average per year.
Looking at the last year, OMI shows a very negative growth in Revenue. The Revenue has decreased by -37.09% in the last year.
OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%

3.2 Future

OMI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.16% yearly.
The Revenue is expected to decrease by -26.97% on average over the next years. This is quite bad
EPS Next Y-31.24%
EPS Next 2Y-19.68%
EPS Next 3Y-9.68%
EPS Next 5Y-1.16%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.44%
Revenue Next 5Y-26.97%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OMI Yearly Revenue VS EstimatesOMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
OMI Yearly EPS VS EstimatesOMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.33, the valuation of OMI can be described as very cheap.
Based on the Price/Earnings ratio, OMI is valued cheaper than 100.00% of the companies in the same industry.
OMI is valuated cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 3.07, the valuation of OMI can be described as very cheap.
Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 99.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OMI to the average of the S&P500 Index (23.78), we can say OMI is valued rather cheaply.
Industry RankSector Rank
PE 2.33
Fwd PE 3.07
OMI Price Earnings VS Forward Price EarningsOMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OMI is valued cheaper than 94.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.08
OMI Per share dataOMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

OMI's earnings are expected to decrease with -9.68% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.11
EPS Next 2Y-19.68%
EPS Next 3Y-9.68%

0

5. Dividend

5.1 Amount

OMI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

OWENS & MINOR INC

NYSE:OMI (12/12/2025, 8:04:00 PM)

After market: 3.07 +0.06 (+1.99%)

3.01

+0.06 (+2.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-26 2026-02-26/amc
Inst Owners96.53%
Inst Owner Change-0.77%
Ins Owners3.54%
Ins Owner Change-0.91%
Market Cap232.82M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Analysts50
Price Target5.75 (91.03%)
Short Float %13.05%
Short Ratio4.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-6.28%
Max EPS beat(2)6.69%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)4.92%
EPS beat(12)10
Avg EPS beat(12)14.96%
EPS beat(16)13
Avg EPS beat(16)13.17%
Revenue beat(2)0
Avg Revenue beat(2)-57.22%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-39.15%
Revenue beat(4)0
Avg Revenue beat(4)-29.25%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-14.86%
Revenue beat(12)4
Avg Revenue beat(12)-9.24%
Revenue beat(16)7
Avg Revenue beat(16)-6.68%
PT rev (1m)-8.66%
PT rev (3m)-8.14%
EPS NQ rev (1m)-1.45%
EPS NQ rev (3m)-6.27%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)2.4%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-37.5%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 2.33
Fwd PE 3.07
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 5.08
EPS(TTM)1.29
EY42.86%
EPS(NY)0.98
Fwd EY32.58%
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS86.71
BVpS-5.55
TBVpS-23.57
PEG (NY)N/A
PEG (5Y)0.11
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROCE 13.12%
ROIC 10.36%
ROICexc 10.59%
ROICexgc 113.35%
OM 3.07%
PM (TTM) N/A
GM 26.13%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3Y-4.88%
ROICexgc growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score2
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 105.46%
Cap/Sales 3.93%
Interest Coverage 1.54
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.84
Altman-Z 1.41
F-Score2
WACC6.72%
ROIC/WACC1.54
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.24%
EPS Next 2Y-19.68%
EPS Next 3Y-9.68%
EPS Next 5Y-1.16%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.44%
Revenue Next 5Y-26.97%
EBIT growth 1Y-30.13%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year23.37%
EBIT Next 3Y7.47%
EBIT Next 5YN/A
FCF growth 1Y-170.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.82%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%

OWENS & MINOR INC / OMI FAQ

Can you provide the ChartMill fundamental rating for OWENS & MINOR INC?

ChartMill assigns a fundamental rating of 3 / 10 to OMI.


What is the valuation status for OMI stock?

ChartMill assigns a valuation rating of 6 / 10 to OWENS & MINOR INC (OMI). This can be considered as Fairly Valued.


What is the profitability of OMI stock?

OWENS & MINOR INC (OMI) has a profitability rating of 4 / 10.


What is the valuation of OWENS & MINOR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for OWENS & MINOR INC (OMI) is 2.33 and the Price/Book (PB) ratio is -0.54.


What is the financial health of OWENS & MINOR INC (OMI) stock?

The financial health rating of OWENS & MINOR INC (OMI) is 1 / 10.